Showing results (1-10 of 382) with videos related to
Sort By:
Pageof 39
Annals of Clinical and Translational Neurology|August 26, 2025
Durability of Response to B-Cell Maturation Antigen-Directed mRNA Cell Therapy in Myasthenia GravisNizar Chahin, Gregory Sahagian, Marc H Feinberg, et al.Annals of Clinical and Translational Neurology|May 27, 2021
Long-term efficacy of eculizumab in refractory generalized myasthenia gravis: responder analysesJames F Howard, Chafic Karam, Marcus Yountz, et al.Rheumatic Diseases Clinics of North America|October 29, 2025
The Mythology of PolymyositisSuur Biliciler, Tahseen MozaffarThe Lancet. Neurology|June 23, 2023
Safety and clinical activity of autologous RNA chimeric antigen receptor T-cell therapy in myasthenia gravis (MG-001): a prospective, multicentre, open-label, non-randomised phase 1b/2a studyVolkan Granit, Michael Benatar, Metin Kurtoglu, et al.Neuropsychiatric Disease and Treatment|December 7, 2023
Ravulizumab in Myasthenia Gravis: A Review of the Current EvidenceTuan Vu, Heinz Wiendl, Masahisa Katsuno, et al.Current Opinion in Neurology|September 7, 2022
Inclusion body myositis: evolving conceptsMari Perez-Rosendahl, Tahseen MozaffarCurrent Treatment Options in Neurology|July 24, 2018
Novel Therapeutic Options in Treatment of Idiopathic Inflammatory MyopathiesNamita A Goyal, Tahseen MozaffarExpert Opinion on Investigational Drugs|June 27, 2014
Experimental trials in amyotrophic lateral sclerosis: a review of recently completed, ongoing and planned trials using existing and novel drugsNamita A Goyal, Tahseen MozaffarNeurology. Genetics|April 12, 2016
Tongue atrophy and fasciculations in transthyretin familial amyloid neuropathy: An ALS mimickerNamita A Goyal, Tahseen MozaffarNeuromuscular Disorders : NMD|April 24, 2008
Myopathy associated with chronic orlistat consumption: a case reportJohn M Ringman, Tahseen MozaffarPageof 39